3-Methylxanthine

3-Methylxanthine

SCHEMBL2791774

BrCCCCBr.Cn1c(=O)[nH]c(=O)c2[nH]cnc21

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 11/20 0.58
PDE4A P27815 10/20 0.58
PDE4B Q07343 10/20 0.58
PDE4C Q08493 10/20 0.58
PDE4D Q08499 10/20 0.58
ADORA2B P29275 6/20 0.57
ADORA3 P0DMS8 3/20 0.57
ADORA1 P30542 2/20 0.57
HPGD P15428 1/20 0.57
BLM P54132 1/20 0.57
PDE3A Q14432 1/20 0.57
HSD17B10 Q99714 1/20 0.57
PNP P00491 1/20 0.48
ATAD2 Q6PL18 1/20 0.46
PIK3CD O00329 1/20 0.45
ALPL P05186 1/20 0.45
TMIGD3 P0DMS9 1/20 0.45
CYP2C19 P33261 1/20 0.45
HIF1A Q16665 1/20 0.45
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Methylxanthine SCHEMBL237146 0.89 ADORA2A (0.64) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL4020124 0.88 ADORA2A (0.62) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL9317914 0.88 ADORA2A (0.62) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL30753411 0.88 ADORA2A (0.62) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL4018085 0.78 ADORA2A (0.52) ADORA2APDE4APDE4BPDE4CPDE4D
3-Methylxanthine SCHEMBL1892894 0.78 ADORA2B (0.77) ADORA2APDE4APDE4BPDE4CPDE4D
Theobromine SCHEMBL4024314 0.77 MAPK1 (0.75) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL17164064 0.76 ATAD2 (0.51) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL3421652 0.74 PDE4A (0.75) ADORA2APDE4APDE4BPDE4CPDE4D
SCHEMBL7602847 0.73 PDE4A (1.00) ADORA2APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168425-A1 ANTIHISTAMINIC AND ANTIALLERGIC AGENT AND A METHOD FOR THE PRODUCTION THEREOF OOO 'FARMVING' (RU) 2010-07-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168425-A1 ANTIHISTAMINIC AND ANTIALLERGIC AGENT AND A METHOD FOR THE PRODUCTION THEREOF HRH2, HRH3, HRH1 ADORA2A 330/4885PDE4A 1001/4885PDE4B 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.